Latest Issues

Search TWST Online

Search by ticker:
or Sector:
Search by keyword:

Subscribe to TWST

The Wall Stree Transcript is a completely unique resource for investors and business researchers. Thousands of in-depth interviews with CEOs, Industry Analysts and Professional Money Managers going back 10 years.

To obtain a copy of a TWST issue/report order online or call (212) 952-7433 .

SUBSCRIBE

Article Excerpt:

Company Interview Excerpt
MICHAEL R. COX - BIOANALYTICAL SYSTEMS, INC.(BASI)


Full article published: 10/30/2006


For Subscribers

Get this article online now!

Order just this article
TWST: We'd like to begin with a brief historical sketch of Bioanalytical Systems and a picture of the things you are doing at the present time.
Mr. Cox: Our company is a contract research organization, one of many in the country. We are probably the smallest publicly traded CRO. It was started 32 years ago by Pete Kissinger, who was a Professor here at Purdue University in West Lafayette. Initially, we were started as an equipment company to provide sensitive measuring instruments to laboratories in the life sciences. As that evolved, we started providing the services that were associated with that, and today, 80% of our revenues are in the service area, dealing with the development of drugs in getting pharmaceuticals to the point of being approvable by the FDA.

TWST: You say you are the smallest of the public companies doing this. What marks you off from the other companies?
Mr. Cox: We compete with them on the same quality and service issues that most service companies do. We set ourselves apart in that the quality of what our professionals do is very highly regarded, and 80% of our business is repeat business. We have a very strong chemistry background - that's what our Founders were in - so the quality of our chemistry is maybe the best in the industry.

 

Tickers included in this excerpt: BASI

 

TWST Newsletter
Fill out your e-mail address
to receive our newsletter!

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.